Companies in the  Technology sector have received a lot of coverage today as analysts  weigh in on Nvidia (NVDA – Research Report), Fiserv (FISV – Research Report) and D-Wave Quantum (QBTS – Research Report).Nvidia (NVDA)Piper Sandler analyst Harsh Kumar  maintained a Buy rating on Nvidia yesterday and set a price target of $225.00. The company’s shares closed last Wednesday at $189.11.
		According to TipRanks.com, Kumar is a top 25 analyst with an average return of 35.0% and a 72.2% success rate. Kumar covers the Technology sector, focusing on stocks such as Advanced Micro Devices, SkyWater Technology, and Skyworks Solutions.Nvidia has an analyst consensus of Strong Buy, with a price target consensus of $264.14, representing a 40.1% upside. In a report issued on December 26, Citi also maintained a Buy rating on the stock with a $270.00 price target.See the top stocks recommended by analysts >>Fiserv (FISV)In a report released today, Darrin Peller  from Wolfe Research maintained a Hold rating on Fiserv. The company’s shares closed last Wednesday at $68.71.
		According to TipRanks.com, Peller is a 5-star analyst with an average return of 9.1% and a 61.9% success rate. Peller covers the Technology sector, focusing on stocks such as Circle Internet Group, Inc. Class A, Jack Henry & Associates, and Euronet Worldwide.Currently, the analyst consensus on Fiserv is a Moderate Buy with an average price target of $99.89, which is a 45.0% upside from current levels. In a report issued on January 5, Monness also maintained a Hold rating on the stock.D-Wave Quantum (QBTS)Wedbush analyst Laura Chico  reiterated a Buy rating on D-Wave Quantum today and set a price target of $35.00. The company’s shares closed last Wednesday at $30.20.According to TipRanks.com, Chico is a 5-star analyst with an average return of 11.1% and a 51.3% success rate. Chico covers the Healthcare sector, focusing on stocks such as Praxis Precision Medicines, Ultragenyx Pharmaceutical, and Viridian Therapeutics.
D-Wave Quantum has an analyst consensus of Strong Buy, with a price target consensus of $40.67, implying a 30.8% upside from current levels. In a report released yesterday, Roth MKM also maintained a Buy rating on the stock with a $40.00 price target.Disclaimer & DisclosureReport an IssueCopyright © 2025
    Insider Inc and finanzen.net GmbH (Imprint). All rights reserved.
    Registration on or use of this site constitutes acceptance of our Terms of Service and Privacy Policy.